SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028296
Filing Date
2018-11-08
Accepted
2018-11-08 08:07:39
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20180930.htm 10-Q 1724012
2 EX-31.1 kzr-ex311_6.htm EX-31.1 18144
3 EX-31.2 kzr-ex312_8.htm EX-31.2 18288
4 EX-32.1 kzr-ex321_7.htm EX-32.1 9212
  Complete submission text file 0001564590-18-028296.txt   5840149

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT kzr-20180930.xml EX-101.INS 1300853
6 XBRL TAXONOMY EXTENSION SCHEMA kzr-20180930.xsd EX-101.SCH 39745
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20180930_cal.xml EX-101.CAL 36927
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20180930_def.xml EX-101.DEF 106883
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20180930_lab.xml EX-101.LAB 302022
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20180930_pre.xml EX-101.PRE 231820
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 181168254
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences